Sino Biopharm received a shareholding of nearly 200 million shares from its subsidiary, how much more will the subsequent shareholding increase? Gapack disclosed that the tender offer for acquisition is still under negotiation, what impact will it have?
Finance Association News on October 4th (Editor Feng Yi) brings you today's important announcements in the Hong Kong stock market.
1) Company News
Gapack (00468.HK): Discussions and negotiations regarding a possible management team tender offer are still ongoing.
Xiwang Property (02088.HK): The receiver has not entered into any formal or legally binding agreements with any third-party buyers for the sale of pledged shares.
Hua Yin Intl H (00989.HK): Termination of loan capitalization agreement and debt restructuring.
I-Control (01402.HK): It is expected that the net loss for the period ending September 30 will increase year-on-year to approximately 14 million-18 million Hong Kong dollars.
Palinda Group (08179.HK): Intends to issue approximately 18.70% of share offer on a basis of one for two, raising up to approximately 71.7 million Hong Kong dollars.
2) Repurchase Dynamics
Sino Biopharm (01177.HK): Subsidiary Zhengda Tianqing has accumulated purchased approximately 0.187 billion shares under the stock incentive plan, with a total cost of approximately 0.551 billion Hong Kong dollars, and a remaining share purchase quota of approximately 0.5 billion RMB.
Tencent (00700.HK): Spending 0.137 billion Hong Kong dollars to repurchase 0.2919 million shares, with a repurchase price per share ranging from 462.4 to 472.2 Hong Kong dollars.
AIA (01299.HK): Spending 42.7437 million Hong Kong dollars to repurchase 0.5934 million shares, with a repurchase price per share ranging from 70.65 to 72.55 Hong Kong dollars.
HSBC Holdings (00005.HK): Spending approximately 0.236 billion Hong Kong dollars to repurchase 3.3964 million shares, with a repurchase price per share ranging from 69.15 to 70.05 Hong Kong dollars.
